|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn581010458 |
003 |
OCoLC |
005 |
20231117033015.0 |
006 |
m o d |
007 |
cr bn||||||abp |
007 |
cr bn||||||ada |
008 |
100326s1981 ja a ob 101 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d UIU
|d OCLCO
|d OCLCF
|d OCLCO
|d N$T
|d NLGGC
|d YDXCP
|d E7B
|d OCLCO
|d EBLCP
|d OCL
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d MERUC
|d OCLCO
|d OCLCA
|d YDX
|d OCLCO
|d OCLCQ
|d STF
|d OCLCO
|d OCLCA
|d UKAHL
|d OCLCQ
|d OCLCO
|d COM
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
066 |
|
|
|c (S
|
019 |
|
|
|a 606493267
|a 896795503
|a 899002864
|a 907119909
|a 974619191
|a 974663375
|a 988559389
|a 1100961772
|a 1154487250
|
020 |
|
|
|a 9781483161594
|q (electronic bk.)
|
020 |
|
|
|a 1483161595
|q (electronic bk.)
|
020 |
|
|
|z 0444804021
|
020 |
|
|
|z 9780444804020
|
035 |
|
|
|a (OCoLC)581010458
|z (OCoLC)606493267
|z (OCoLC)896795503
|z (OCoLC)899002864
|z (OCoLC)907119909
|z (OCoLC)974619191
|z (OCoLC)974663375
|z (OCoLC)988559389
|z (OCoLC)1100961772
|z (OCoLC)1154487250
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a RM328
|b .I56 1981
|
060 |
|
4 |
|a QU 68
|b I596a 1981
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.7822
|2 19
|
111 |
2 |
|
|a International Narcotics Research Conference
|d (1981 :
|c Kyoto, Japan)
|
245 |
1 |
0 |
|a Advances in endogenous and exogenous opioids :
|b proceedings of the International Narcotic Research Conference (satellite symposium of the 8th International Congress of Pharmacology), held in Kyoto, Japan on July 26-30, 1981 /
|c edited by Hiroshi Takagi, Eric J. Simon.
|
260 |
|
|
|a Tokyo :
|b Kodansha ;
|a Amsterdam ;
|a New York :
|b Elsevier Biomedical Press ;
|a New York :
|b Distributors for the US and Canada, Elsevier Science Pub. Co.,
|c 1981.
|
300 |
|
|
|a 1 online resource (xxvi, 493 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
588 |
0 |
|
|a Print version record.
|
505 |
8 |
|
|6 880-01
|a BIOCHEMICAL EVIDENCE FOR KAPPA AND SIGMA OPIATE RECEPTORSSUMMARY; INTRODUCTION; METHODS; RESULTS; DISCUSSION; REFERENCES; Chapter 4. CHARACTERIZATION OF DYNORPHIN RECEPTOR SPECIFICITY IN THE GUINEA PIG ILEUM; SUMMARY; REFERENCES; Chapter 5. OPIATE RECEPTORS IN THE GUINEA-PIG ILEAL MUCOSA; SUMMARY; INTRODUCTION; METHODS; REFERENCES; Chapter 6. OPIATE BINDING SITES IN THE LUMBO-SACRAL SPINAL CORD FROM VARIOUS SPECIES; SUMMARY; INTRODUCTION; METHODS; RESULTS; DISCUSSION; REFERENCES; Chapter 7. EFFECTS OF OPIOID PEPTIDES AND KAPPA-RECEPTOR AGONISTS ON IN VITRO ISOLATEDPREPARATIONS; SUMMARY.
|
505 |
8 |
|
|a INTRODUCTIONMETHODS; RESULTS; DISCUSSION; REFERENCES; Chapter 8. MULTIPLE BENZOMORPHAN BINDING SITES IN A CLONAL CELL LINE; SUMMARY; METHODS; DISCUSSION; REFERENCES; Chapter 9. MORPHINE AND OXYMORPHONE ACT AS PARTIAL AGONISTS ON THE FIELD STIMULATED RAT VAS DEFERENS; SUMMARY; INTRODUCTION; METHODS; RESULTS; DISCUSSION; REFERENCES; Chapter 10. SPECIFIC OPIATE BINDING SITES IN HUMAN PLACENTA; SUMMARY; INTRODUCTION; METHODS; RESULTS; DISCUSSION; REFERENCES; Chapter 11. MULTIPLE BINDING SITES FOR 3H-ETHYLKETOCYCLAZOCINE ON THE LUMBO-SACRAL PORTIONOF THE GUINEA-PIG SPINAL CORD; SUMMARY.
|
505 |
8 |
|
|6 880-02
|a Chapter 14. POTENCIES OF ""MU"" AND ""KAPPA"" AGONISTS ON SMOOTH MUSCLE PREPARATIONS RELATIVE TO DISPLACEMENT OF 3H-ETORPHINE IN ISOLATED RAT BRAIN NEURAL MEMBRANESSUMMARY; INTRODUCTION; METHODS; RESULTS AND DISCUSSION; ACKNOWLEDGEMENT; REFERENCES; Chapter 15. COMPARISON OF 3H-ETORPHINE AND 3H-DIPRENORPHINE RECEPTOR BINDING IN VIVO AND IN VITRO; SUMMARY; INTRODUCTION; METHODS; RESULTS; DISCUSSION; REFERENCES; Chapter 16. TENTATIVE IDENTIFICATION OF HIGH AFFINITY OPIOID BINDING SITES IN THE PEDAL GANGLIA OF THE MARINE MUSSEL Mytilus edulis; SUMMARY; INTRODUCTION; METHODS; RESULTS; DISCUSSION.
|
520 |
|
|
|a Advances in Endogenous and Exogenous Opioids.
|
650 |
|
0 |
|a Narcotics
|v Congresses.
|
650 |
|
0 |
|a Endorphins
|v Congresses.
|
650 |
|
0 |
|a Opioids
|v Congresses.
|
650 |
|
0 |
|a Neuropharmacology
|v Congresses.
|
650 |
|
0 |
|a Endorphins
|x Congresses.
|
650 |
|
0 |
|a Neuropharmacology
|x Congresses.
|
650 |
|
0 |
|a Drug tolerance.
|
650 |
|
0 |
|a Endorphins.
|
650 |
|
2 |
|a Drug Tolerance
|0 (DNLM)D004361
|
650 |
|
2 |
|a Endorphins
|0 (DNLM)D004723
|
650 |
|
2 |
|a Narcotics
|0 (DNLM)D009294
|
650 |
|
2 |
|a Substance-Related Disorders
|0 (DNLM)D019966
|
650 |
|
6 |
|a Drogues
|0 (CaQQLa)201-0005664
|x Congr�es.
|0 (CaQQLa)201-0378208
|
650 |
|
6 |
|a Endorphines
|0 (CaQQLa)201-0006526
|x Congr�es.
|0 (CaQQLa)201-0378208
|
650 |
|
6 |
|a Neuropharmacologie
|0 (CaQQLa)201-0038270
|x Congr�es.
|0 (CaQQLa)201-0378208
|
650 |
|
6 |
|a Drogues
|0 (CaQQLa)201-0005664
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Endorphines
|0 (CaQQLa)201-0006526
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Opio�ides
|0 (CaQQLa)201-0006529
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Neuropharmacologie
|0 (CaQQLa)201-0038270
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Tol�erance aux m�edicaments.
|0 (CaQQLa)201-0128980
|
650 |
|
6 |
|a Endorphines.
|0 (CaQQLa)201-0006526
|
650 |
|
6 |
|a Drogues.
|0 (CaQQLa)201-0005664
|
650 |
|
6 |
|a Toxicomanie.
|0 (CaQQLa)201-0014203
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Drug tolerance
|2 fast
|0 (OCoLC)fst00898721
|
650 |
|
7 |
|a Endorphins
|2 fast
|0 (OCoLC)fst00909802
|
650 |
|
7 |
|a Narcotics
|2 fast
|0 (OCoLC)fst01032860
|
650 |
|
7 |
|a Neuropharmacology
|2 fast
|0 (OCoLC)fst01036458
|
650 |
|
7 |
|a Opioids
|2 fast
|0 (OCoLC)fst01046544
|
655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|0 (CStmoGRI)aatgf300027316
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|0 (OCoLC)fst01423772
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
700 |
1 |
|
|a Takagi, Hiroshi.
|
700 |
1 |
|
|a Simon, Eric J.
|
711 |
2 |
|
|a International Congress of Pharmacology
|n (8th :
|d 1981 :
|c Tokyo, Japan)
|
776 |
0 |
8 |
|i Print version:
|a International Narcotics Research Conference (1981 : Kyoto, Japan).
|t Advances in endogenous and exogenous opioids.
|d Tokyo : Kodansha ; Amsterdam ; New York : Elsevier Biomedical Press ; New York : Distributors for the US and Canada, Elsevier Science Pub. Co., 1981
|w (DLC) 81019570
|w (OCoLC)8050904
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780444804020
|z Texto completo
|
880 |
0 |
|
|6 505-01/(S
|a Front Cover; Advances in Endogenous and Exogenous Opioids; Copyright Page; Preface; Acknowledgements; List of Participants; Table of Contents; Part I: MULTIPLE OPIOID RECEPTORS; Chapter 1. THE INTERACTION OF OPIOID PEPTIDES AND ALKALOID OPIATES WITH μ-, δ- AND κ- BINDING SITES; INTRODUCTION; METHODS; RESULTS; ACKNOWLEDGEMENTS; REFERENCES; Chapter 2. CHARACTERIZATION OF NOVEL OPIATE BINDING SITES SELECTIVE FOR BENZOMORPHAN DRUGS; SUMMARY; INTRODUCTION; METHODS; RESULTS AND DISCUSSION; REFERENCES; Chapter 3. BIOCHEMICAL EVIDENCE FOR KAPPA AND SIGMA OPIATE RECEPTORS.
|
880 |
8 |
|
|6 505-02/(S
|a INTRODUCTIONMETHODS; RESULTS; DISCUSSION; REFERENCES; Chapter 12. DIFFERENTIAL INTERACTIONS OF DYNORPHIN(1-13), β-ENDORPHIN, AND ENKEPHALIN-RELATED PEPTIDES AT μ AND δ SITES IN DIFFERENT BRAIN REGIONS; SUMMARY; INTRODUCTION; METHODS; RESULTS; DISCUSSION; REFERENCES; Chapter 13. DIFFERENTIAL EFFECTS OF ISOMERS OF OPIOID ANTAGONISTS UPON μ-, K- and δ AGONIST ANALGESIA: COMPARISON WITH OXOTREMORINE.; SUMMARY; INTRODUCTION; METHODS; RESULTS; DISCUSSION; REFERENCES.
|